In addition, patients diagnosed with bulimia nervosa disorder were excluded from the study, however, patients were not screened or monitored for eating disorders during the treatment phase
FDA Warns Novo Nordisk on Unreported Deaths CEO & Founder at LlamaLab FDA Cites 'Systemic Failures' in Novo Nordisk's Reporting of Ozempic Deaths The FDA issued a warning letter to Novo Nordisk on March 5, 2026, citing "systemic failures" in the company's adverse event reporting for its semaglutide and liraglutide drugs including at least two unreported patient deaths and a suicide case that had still not been submitted to the FDA as of the letter's date
While some individuals may experience weight loss every week while taking semaglutide, weight loss progress can vary from person to person
For large breeds like German Shepherds, Labradors, and Golden Retrievers, joint degeneration often starts earlier
In Frontiers in Endocrinology (Vol